Analysis of genes coding for CD46, CD55, and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy loss

European Journal of Immunology

Volumn 43, Issue 6, 2013, Pages 1617-1629

  Mohlin, Frida C ^a   Mercier, Eric ^b   Fremeaux Bacchi, Veronique ^c   Liszewski, M Kathryn ^d   Atkinson, John P ^d   Gris, Jean Christophe ^b   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

^b NÎMES UNIVERSITY HOSPITAL   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complement inhibitor; Complement system; Mutation; Reproductive immunology

Indexed keywords

COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT COMPONENT C4B BINDING PROTEIN ALPHA; COMPLEMENT COMPONENT C4B BINDING PROTEIN BETA; DECAY ACCELERATING FACTOR; FIBRINOGEN; MEMBRANE COFACTOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXON; FEMALE; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RECURRENT ABORTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; ANTIGENS, CD46; ANTIGENS, CD55; COMPLEMENT C4B-BINDING PROTEIN; DNA MUTATIONAL ANALYSIS; FEMALE; FIBRINOGEN; HUMANS; MUTATION; POLYMORPHISM, GENETIC; PREGNANCY;

EID: 84879469163     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243196     Document Type: Article

References (32)

1. Rai, R. and Regan, L., Recurrent miscarriage. Lancet 2006. 368: 601-611.
2. Tincani, A., Cavazzana, I., Ziglioli, T., Lojacono, A., De Angelis, V. and Meroni, P., Complement activation and pregnancy failure. Clin. Rev. Allergy Immunol. 2009. 39: 153-159.
3. Xu, C., Mao, D., Holers, V. M., Palanca, B., Cheng, A. M. and Molina, H., A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000. 287: 498-501.
4. Kask, L., Hillarp, A., Ramesh, B., Dahlback, B. and Blom, A. M., Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry 2002. 41: 9349-9357.
5. Trouw, L. A., Bengtsson, A. A., Gelderman, K. A., Dahlbäck, B., Sturfelt, G. and Blom, A. M., C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. J. Biol. Chem. 2007. 282: 28540-28548.
6. Trouw, L. A., Nilsson, S. C., Goncalves, I., Landberg, G. and Blom, A. M., C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 2005. 201: 1937-1948.
7. Lee, J., Oh, J., Choi, E., Park, I., Han, C., Kim do, H., Choi, B. C. et al., Differentially expressed genes implicated in unexplained recurrent spontaneous abortion. Int. J. Biochem. Cell Biol. 2007. 39: 2265-2277.
8. Risk, J. M., Flanagan, B. F. and Johnson, P. M., Polymorphism of the human CD46 gene in normal individuals and in recurrent spontaneous abortion. Hum. Immunol. 1991. 30: 162-167.
9. Wang, Z. C., Hill, J. A., Yunis, E. J., Xiao, L. and Anderson, D. J., Maternal CD46H*2 and IL1B-511*1 homozygosity in T helper 1-type immunity to trophoblast antigens in recurrent pregnancy loss. Hum. Reprod. 2006. 21: 818-822.
10. Salmon, J. E., Heuser, C., Triebwasser, M., Liszewski, M. K., Kavanagh, D., Roumenina, L., Branch, D. W. et al., Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011. 8: e1001013.
11. Cunningham, D. S. and Tichenor, J. R., Jr., Decay-accelerating factor protects human trophoblast from complement-mediated attack. Clin. Immunol. Immunopathol. 1995. 74: 156-161.
12. Francis, J., Rai, R., Sebire, N. J., El-Gaddal, S., Fernandes, M. S., Jindal, P., Lokugamage, A. et al., Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome. Mol. Hum Reprod. 2006. 12: 435-442.
13. Blom, A. M., Bergstrom, F., Edey, M., Diaz-Torres, M., Kavanagh, D., Lampe, A., Goodship, J. A. et al., A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity. J. Immunol. 2008. 180: 6385-6391.
14. Fang, C. J., Fremeaux-Bacchi, V., Liszewski, M. K., Pianetti, G., Noris, M., Goodship, T. H. and Atkinson, J. P., Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 2008. 111: 624-632.
15. Fremeaux-Bacchi, V., Moulton, E. A., Kavanagh, D., Dragon-Durey, M. A., Blouin, J., Caudy, A., Arzouk, N. et al., Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2006. 17: 2017-2025.
16. Ballard, L. L., Bora, N. S., Yu, G. H. and Atkinson, J. P., Biochemical characterization of membrane cofactor protein of the complement system. J. Immunol. 1988. 141: 3923-3929.
17. Blom, A. M., A cluster of positively charged amino acids in the alpha-chain of C4b-binding protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria. Scand. J. Clin. Lab. Invest. (Suppl) 2000. 233: 37-49.
18. Blom, A. M., Kask, L. and Dahlbäck, B., Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 2001. 276: 27136-27144.
19. Blom, A. M., Kask, L. and Dahlback, B., CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. Mol. Immunol. 2003. 39: 547-556.
20. Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Muslumanoglu, M. H. et al., Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl. Acad. Sci. USA 2003. 100: 12966-12971.
21. Liszewski, M. K., Kemper, C., Price, J. D. and Atkinson, J. P., Emerging roles and new functions of CD46. Springer Semin. Immunopathol. 2005. 27: 345-358.
22. Liszewski, M. K., Leung, M., Cui, W., Subramanian, V. B., Parkinson, J., Barlow, P. N., Manchester, M. et al., Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J. Biol. Chem. 2000. 275: 37692-37701.
23. Malina, M., Roumenina, L. T., Seeman, T., Le Quintrec, M., Dragon-Durey, M. A., Schaefer, F. and Fremeaux-Bacchi, V., Genetics of hemolytic uremic syndromes. Presse Med. 2012. 41: e105-e114.
24. Perez-Caballero, D., Gonzalez-Rubio, C., Gallardo, M. E., Vera, M., Lopez-Trascasa, M., Rodriguez de Cordoba, S. and Sanchez-Corral, P., Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am. J. Hum. Genet. 2001. 68: 478-484.
25. Fremeaux-Bacchi, V., Dragon-Durey, M. A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C. et al., Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J. Med. Genet. 2004. 41: e84.
26. Greenwood, F. C., Hunter, W. M. and Glover, J. S., The Preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem. J. 1963. 89: 114-123.
27. Crossley, L. G. and Porter, R. R., Purification of the human complement control protein C3b inactivator. Biochem. J. 1980. 191: 173-182.
28. Liszewski, M. K., Farries, T. C., Lublin, D. M., Rooney, I. A. and Atkinson, J. P., Control of the complement system. Adv. Immunol. 1996. 61: 201-283.
29. Manchester, M., Valsamakis, A., Kaufman, R., Liszewski, K., Alvarez, J., Atkinson, J. P., Lublin, D. M. et al., Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc. Natl. Acad. Sci. USA 1995. 92: 2303-2307.
30. Liszewski, M. K. and Atkinson, J. P., Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement. J. Immunol. 1996. 156: 4415-4421.
31. Liszewski, M. K., Leung, M. K. and Atkinson, J. P., Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. J. Immunol. 1998. 161: 3711-3718.
32. Zadura, A. F., Theander, E., Blom, A. M. and Trouw, L. A., Complement inhibitor C4b-binding protein in primary Sjogren's syndrome and its association with other disease markers. Scand. J. Immunol. 2009. 69: 374-380.